International Clinical Trial: A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07525947) titled 'A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants' on April 6.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Sequential Assignment. Primary purpose: Basic Science. Masking: None (Open Label).

Primary Sponsor: Jade Biosciences, Inc.

Condition: Healthy Volunteers (HV)

Intervention: Drug: JADE101

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: May 2026

Target Sample Size: 40

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07525947

Published by HT Digi...